PharmaFluidics
De berekende faillissementskans van PharmaFluidics over 12 maanden bedraagt 0,1% (zeer laag). Het bedrijf is actief sinds 2010 en het Belgisch Staatsblad bevat geen insolventie- of waarschuwingssignalen. Er zijn geen verwerkte jaarrekeningcijfers beschikbaar; deze conclusie steunt uitsluitend op register- en Staatsbladgegevens.
| Actief | 15 jaar |
| Vestigingen | 1 |
| Publicaties | 33 |
Statistische inschatting op basis van openbare bronnen, geen kredietadvies of vaststelling. Hoe berekenen we dit?
| Boekjaar | Type | Neerlegging | Referentie |
|---|---|---|---|
| 31-12-2025 | verkort | 08-06-2026 | 2026-00153437 |
| 31-12-2024 | verkort | 11-06-2025 | 2025-00151169 |
| 31-12-2023 | verkort | 26-07-2024 | 2024-00305440 |
| 31-12-2022 | verkort | 14-07-2023 | 2023-00258902 |
| 31-12-2021 | verkort | 12-07-2022 | 2022-20187112 |
| 31-12-2020 | verkort | 08-06-2021 | 2021-18900600 |
| 31-12-2019 | verkort | 03-07-2020 | 2020-26800021 |
| 31-12-2018 | verkort | 15-07-2019 | 2019-33500184 |
| 31-12-2017 | verkort | 29-06-2018 | 2018-29200217 |
| 31-12-2016 | verkort | 06-06-2017 | 2017-15100560 |
| NACE primair | Gezondheidszorg(86910) |
| Rechtsvorm | NV(014) |
| Oprichtingsdatum | 29-12-2010 |
| Status | Actief |
| Postcode | 9052 |
Percelen gekoppeld aan dit bedrijf via zijn adressen in de KBO (zetel, vestigingen, bijkantoren), gekruist met het kadastraal percelenplan. Dit toont waar het bedrijf actief is, geen eigendomsregister.
| Perceel (capakey) | Regio | Oppervlakte | Gebouwen | Hoogte / verd. |
|---|---|---|---|---|
| 44082B0143/00K000 | Vlaanderen | 2.851 m² | 1 · 1.922 m² | 6,3 m · 2 verd. |
Eén tijdlijn van alles wat er met dit bedrijf is gebeurd, publicaties, insolventie- en levensloopgebeurtenissen, administratieve wijzigingen en neergelegde jaarrekeningen.
03-10-2025 1 bestuurder benoemd, 1 ontslagnemend
- Paul JACOBS, Bestuurder
- Yves MOENS, Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Yves MOENS",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Paul JACOBS",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0832.350.565",
"name_full": "PHARMAFLUIDICS"
}
}07-07-2025 2 ontslagnemend
- Ines Brückel, Dagelijks bestuurder
- Marion Murail, Dagelijks bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "dagelijks bestuurder",
"person": {
"rrn": null,
"name": "Ines Br\u00FCckel",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "dagelijks bestuurder",
"person": {
"rrn": null,
"name": "Marion Murail",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0832.350.565",
"name_full": "PHARMAFLUIDICS"
}
}26-02-2025 Wijziging in het bestuur
Technische details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0832.350.565",
"name_full": "PHARMAFLUIDICS"
}
}29-02-2024 Kapitaalvermindering van €1 tot €21.854.945,46
- €21.854.946,46 → €21.854.945,46
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_decrease",
"after_eur": 21854945.46,
"delta_eur": -1.0,
"before_eur": 21854946.46,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0832.350.565",
"name_full": "PharmaFluidics"
}
}20-12-2023 Kapitaalverhoging van €20.000.000 tot €21.854.946,46
- €1.854.946,46 → €21.854.946,46
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 21854946.46,
"delta_eur": 20000000.0,
"before_eur": 1854946.46,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0832.350.565",
"name_full": "PharmaFluidics"
}
}11-10-2023 Franciscus VAN VEEN neemt ontslag als bestuurder
- Franciscus VAN VEEN, Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Franciscus VAN VEEN",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0832.350.565",
"name_full": "PHARMAFLUIDICS"
}
}05-09-2023 BDO Bedrijfsrevisoren benoemd tot commissaris
- BDO Bedrijfsrevisoren, Commissaris
Technische details
{
"events": [
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "BDO Bedrijfsrevisoren",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0832.350.565",
"name_full": "PHARMAFLUIDICS"
}
}31-08-2022 3 bestuurders benoemd, 2 ontslagnemend
- Paul JACOBS, Dagelijks bestuurder
- Ines BRUECKEL, Dagelijks bestuurder
- Marion MURAIL, Dagelijks bestuurder
- Johan DEVENYNS, Dagelijks bestuurder
- Bart CATRYSSE, Dagelijks bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "dagelijks bestuurder",
"person": {
"rrn": null,
"name": "Johan DEVENYNS",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "dagelijks bestuurder",
"person": {
"rrn": null,
"name": "Bart CATRYSSE",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "dagelijks bestuurder",
"person": {
"rrn": null,
"name": "Paul JACOBS",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "dagelijks bestuurder",
"person": {
"rrn": null,
"name": "Ines BRUECKEL",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "dagelijks bestuurder",
"person": {
"rrn": null,
"name": "Marion MURAIL",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0832.350.565",
"name_full": "PHARMAFLUIDICS"
}
}08-11-2021 2 bestuurders benoemd, 2 ontslagnemend
- Johan Devenyns, Dagelijks bestuur
- Bart Catrysse, Dagelijks bestuur
- Johan Devenyns, Dagelijks bestuur
- Acorus BV, Dagelijks bestuur
Technische details
{
"events": [
{
"kind": "director_in",
"role": "dagelijks bestuur",
"person": {
"rrn": null,
"name": "Johan Devenyns",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "dagelijks bestuur",
"person": {
"rrn": null,
"name": "Bart Catrysse",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "dagelijks bestuur",
"person": {
"rrn": null,
"name": "Johan Devenyns",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "dagelijks bestuur",
"person": {
"rrn": null,
"name": "Acorus BV",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0832.350.565",
"name_full": "PharmaFluidics"
}
}01-10-2021 Statutenwijziging
Technische details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": true
},
"subject_company": {
"kbo": "0832.350.565",
"name_full": "PharmaFluidics"
},
"legal_form_change": {
"new": "naamloze vennootschap",
"old": "naamloze vennootschap",
"changed": false
}
}06-09-2021 1 bestuurder benoemd, 1 ontslagnemend
- Tine Bekaert, Vaste vertegenwoordiger van bestuurder
- Jeroen Van den Bossche, Vaste vertegenwoordiger van bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "vaste vertegenwoordiger van bestuurder",
"person": {
"rrn": null,
"name": "Jeroen Van den Bossche",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "vaste vertegenwoordiger van bestuurder",
"person": {
"rrn": null,
"name": "Tine Bekaert",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0832.350.565",
"name_full": "PharmaFluidics"
}
}02-09-2021 Kapitaalverhoging van €1.083.885,22 tot €12.037.031,57
- €10.953.146,35 → €12.037.031,57
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 12037031.57,
"delta_eur": 1083885.2200000007,
"before_eur": 10953146.35,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0832.350.565",
"name_full": "PharmaFluidics"
}
}02-09-2021 Publicatie in het Belgisch Staatsblad, Diversen
Technische details
{
"stage": null,
"notary": {
"name": "Ward BULTEREYS",
"firm_city": null,
"firm_name": "HENRIST, DE MULDER EN BULTEREYS, GEASSOCIEERDE NOTARISSEN",
"office_city": "Merelbeke (Bottelare)",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2021-09-02",
"filing_date": "2021-08-31",
"act_kind_objet": "DIVERSEN"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2021-08-24",
"unanimous": null
},
"conversion": null,
"detected_kind": "other",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0832.350.565",
"name": "PharmaFluidics",
"role": "other",
"address": "Technologiepark-Zwijnaarde 82, 9052 Gent",
"is_foreign": false,
"legal_form": "Naamloze vennootschap",
"is_new_company": false,
"jurisdiction_country": "BE"
}
],
"exchange_ratio": null,
"legal_articles": [],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": null,
"real_estate_included": false,
"patrimony_description": "De overdracht van vermogen betreft de annulatie en vernietiging van \u0027Adjustment Warrants\u0027 uitgegeven door de vennootschap, inclusief drie \u0027Adjustment Warrants I\u0027 en drie \u0027Adjustment Warrants II\u0027 uit 2017.",
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0832.350.565",
"name_full": "PharmaFluidics",
"legal_form": "Naamloze vennootschap"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "Baker McKenzie",
"person_name": null,
"org_rep_person_name": "Kristoff Cox"
},
"summary_narrative": "De buitengewone algemene vergadering van PharmaFluidics besliste op 24 augustus 2021 tot annulatie en vernietiging van alle \u0027Adjustment Warrants\u0027 uitgegeven door de vennootschap, met inbegrip van drie \u0027Adjustment Warrants I\u0027 en drie \u0027Adjustment Warrants II\u0027 uit 2017. De vergadering verleende daarna machten aan het bestuursorgaan, de notaris en bepaalde vertegenwoordigers van Baker McKenzie voor de uitvoering van de besluiten en de formaliteiten bij de Kruispuntbank van Ondernemingen.",
"co_filed_documents": [
"uitgifte van het proces-verbaal",
"aanwezigheidslijst met daaraan gehecht zevenentwintig (27) volmachten"
],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": "statutes"
}02-08-2021 Kapitaalverhoging van €2.547.937,90 tot €10.953.146,35
- €8.405.208,45 → €10.953.146,35
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 10953146.35,
"delta_eur": 2547937.9000000004,
"before_eur": 8405208.45,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0832.350.565",
"name_full": "PharmaFluidics"
}
}08-12-2020 1 bestuurder benoemd, 1 ontslagnemend
- Jeroen Van den Bossche, Vaste vertegenwoordiger bestuurder
- Philippe Stas, Vaste vertegenwoordiger bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "vaste vertegenwoordiger bestuurder",
"person": {
"rrn": null,
"name": "Philippe Stas",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "vaste vertegenwoordiger bestuurder",
"person": {
"rrn": null,
"name": "Jeroen Van den Bossche",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0832.350.565",
"name_full": "PharmaFluidics"
}
}09-09-2020 Verrichting in kapitaal of aandelen
Technische details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0832.350.565",
"name_full": "PharmaFluidics"
}
}23-06-2020 4 bestuurders benoemd, 3 ontslagnemend
- PMV NV, Bestuurder
- Heran Partners BV, Bestuurder
- RR-Invest Sàrl, Bestuurder
- BDO Bedrijfsrevisoren, Commissaris
- David Devigne, Bestuurder
- Annie Vereecken, Bestuurder
- Rudi Mariën, Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "David Devigne",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "PMV NV",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Annie Vereecken",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Heran Partners BV",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Rudi Mari\u00EBn",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "RR-Invest S\u00E0rl",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "BDO Bedrijfsrevisoren",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0832.350.565",
"name_full": "PharmaFluidics"
}
}30-12-2019 Kapitaalvermindering van €9.535.278,68 tot €5.202.183,34
- €14.737.462,02 → €5.202.183,34
Technische details
{
"events": [
{
"kind": "capital_decrease",
"after_eur": 5202183.34,
"delta_eur": -9535278.68,
"before_eur": 14737462.02,
"contribution_type": null
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0832.350.565",
"name_full": "PharmaFluidics"
}
}19-11-2019 1 bestuurder benoemd, 1 ontslagnemend
- Veerle Catry, Vaste vertegenwoordiger commissaris
- Bert Kegels, Vaste vertegenwoordiger commissaris
Technische details
{
"events": [
{
"kind": "director_out",
"role": "vaste vertegenwoordiger commissaris",
"person": {
"rrn": null,
"name": "Bert Kegels",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "vaste vertegenwoordiger commissaris",
"person": {
"rrn": null,
"name": "Veerle Catry",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0832.350.565",
"name_full": "PharmaFluidics"
}
}08-07-2019 Kapitaalverhoging van €856.276,67 tot €12.493.744,42
- €11.637.467,75 → €12.493.744,42
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 12493744.42,
"delta_eur": 856276.6699999999,
"before_eur": 11637467.75,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0832.350.565",
"name_full": "PharmaFluidics"
}
}12-02-2019 Zetelverplaatsing binnen Zwijnaarde
- Technologiepark Zwijnaarde 3, 9052 Zwijnaarde → Technologiepark 82, 9052 Zwijnaarde
Technische details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "Technologiepark 82, 9052 Zwijnaarde",
"city": "Zwijnaarde",
"region": "vlaams_gewest",
"street": "Technologiepark",
"country": "BE",
"postcode": "9052",
"box_number": null,
"street_number": "82",
"locality_suffix": null
},
"old_address": {
"raw": "Technologiepark Zwijnaarde 3, 9052 Zwijnaarde",
"city": "Zwijnaarde",
"region": "vlaams_gewest",
"street": "Technologiepark Zwijnaarde",
"country": "BE",
"postcode": "9052",
"box_number": null,
"street_number": "3",
"locality_suffix": null
},
"effective_date": "2019-01-01",
"evidence_quote": "De Raad van Bestuur neemt kennis van de beslissing van de Stad Gent tot de doorvoering van een hernummering in het Technologiepark te Zwijnaarde, waardoor het adres van de maatschappelijke zetel van de vennootschap per 1 januari 2019 gewijzigd wordt naar: Technologiepark 82, 9052 Zwijnaarde.",
"region_changed": false,
"is_statute_change": false,
"nationality_change": false,
"old_address_source": "act_body",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "absolute",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
}
],
"notary": {
"name": "Acorus BVBA",
"firm_city": null,
"firm_name": null,
"office_city": "Gent",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2019-02-12",
"filing_date": "2019-01-31",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "raad_van_bestuur",
"date": "2018-12-18",
"unanimous": true
},
"subject_company": {
"kbo": "0832.350.565",
"name_full": "PharmaFluidics",
"legal_form": "NV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Johan Devenyns",
"org_rep_person_name": null,
"person_role_at_subject": "Gedelegeerd bestuurder"
},
"co_filed_documents": [
"Uittreksel uit het verslag van de Raad van Bestuur van 18 december 2018"
]
}08-02-2019 1 bestuurder benoemd, 1 ontslagnemend
- Gert Desmet, A bestuurder
- Kastel BVBA, Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Kastel BVBA",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "A-Bestuurder",
"person": {
"rrn": null,
"name": "Gert Desmet",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0832.350.565",
"name_full": "PharmaFluidics"
}
}22-01-2018 Kapitaalverhoging van €4.535.699,10 tot €8.905.414,55
- €4.369.715,45 → €8.905.414,55
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 8905414.55,
"delta_eur": 4535699.100000001,
"before_eur": 4369715.45,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0832.350.565",
"name_full": "PHARMAFLUIDICS"
}
}06-10-2017 2 bestuurders benoemd
- BDO Bedrijfsrevisoren, Commissaris
- Farajollah Fashad (Fasha) Mahjoor, Onafhankelijk bestuurder
Technische details
{
"events": [
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "BDO Bedrijfsrevisoren",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "onafhankelijk bestuurder",
"person": {
"rrn": null,
"name": "Farajollah Fashad (Fasha) Mahjoor",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0832.350.565",
"name_full": "PharmaFluidics"
}
}05-09-2017 Kapitaalverhoging van €1.019.184 tot €4.369.715,45
- €3.350.531,45 → €4.369.715,45
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 4369715.45,
"delta_eur": 1019184.0,
"before_eur": 3350531.45,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0832.350.565",
"name_full": "PHARMAFLUIDICS"
}
}27-04-2017 1 bestuurder benoemd, 1 ontslagnemend
- Marie Bouillez, Vaste vertegenwoordiger
- Jean Van Nuwenborg, Vaste vertegenwoordiger
Technische details
{
"events": [
{
"kind": "director_out",
"role": "vaste vertegenwoordiger",
"person": {
"rrn": null,
"name": "Jean Van Nuwenborg",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "vaste vertegenwoordiger",
"person": {
"rrn": null,
"name": "Marie Bouillez",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0832.350.565",
"name_full": "PHARMAFLUIDICS"
}
}02-02-2017 Kapitaalverhoging van €92.944,38 tot €3.340.299,83
- €3.247.355,45 → €3.340.299,83
- Inbreng in natura · Apport en nature
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 3340299.83,
"delta_eur": 92944.37999999989,
"before_eur": 3247355.45,
"contribution_type": "natura"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0832.350.565",
"name_full": "PHARMAFLUIDICS"
}
}12-01-2017 10 bestuurders benoemd, 1 ontslagnemend
- DE MALSCHE Wim, Bestuurder a
- DEVIGNE David Jacques Martine, Bestuurder b
- GONNISSEN Danny Henri Jean Marie, Bestuurder b
- THEODORUS III, Bestuurder b
- VAN NUWENBORG Jean Emile Léon Joseph, Bestuurder b
- VERLEYSEN Katleen Rita Jozef Mariette Julien, Onafhankelijke bestuurder
- SAS K.B.K., Onafhankelijke bestuurder
- DESMET Gert, Gewone bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "LABEUR Christine",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder A",
"person": {
"rrn": null,
"name": "DE MALSCHE Wim",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder B",
"person": {
"rrn": null,
"name": "DEVIGNE David Jacques Martine",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder B",
"person": {
"rrn": null,
"name": "GONNISSEN Danny Henri Jean Marie",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder B",
"person": {
"rrn": null,
"name": "THEODORUS III",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder B",
"person": {
"rrn": null,
"name": "VAN NUWENBORG Jean Emile L\u00E9on Joseph",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "onafhankelijke bestuurder",
"person": {
"rrn": null,
"name": "VERLEYSEN Katleen Rita Jozef Mariette Julien",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "onafhankelijke bestuurder",
"person": {
"rrn": null,
"name": "SAS K.B.K.",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "gewone bestuurder",
"person": {
"rrn": null,
"name": "DESMET Gert",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "gedelegeerd bestuurder",
"person": {
"rrn": null,
"name": "ACORUS",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "gedelegeerd bestuurder",
"person": {
"rrn": null,
"name": "DEVENYNS Johan Andr\u00E9 Hubert",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0832.350.565",
"name_full": "PHARMAFLUIDICS"
}
}14-10-2016 1 bestuurder benoemd, 1 ontslagnemend
- BVBA ACORUS, Bestuurder
- BVBA J&P, Dagelijks bestuurder
Technische details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "BVBA ACORUS",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "dagelijks bestuurder",
"person": {
"rrn": null,
"name": "BVBA J\u0026P",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0832.350.565",
"name_full": "PHARMAFLUIDICS"
}
}30-08-2016 Publicatie in het Belgisch Staatsblad, Diversen
Technische details
{
"stage": null,
"notary": {
"name": "J\u0026P BVBA",
"firm_city": null,
"firm_name": null,
"office_city": "Gent",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2016-08-30",
"filing_date": "2016-08-18",
"act_kind_objet": "Neerlegging besluiten overeenkomstig art. 556 W. Venn."
},
"decision": {
"body": "bijzondere_algemene_vergadering",
"act_date": "2016-07-06",
"unanimous": null
},
"conversion": null,
"detected_kind": "other",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0832.350.565",
"name": "Pharmafluidics",
"role": "other",
"address": "Technologiepark Zwijnaarde 3, 9052 Zwijnaarde",
"is_foreign": false,
"legal_form": "Naamloze Vennootschap",
"is_new_company": false,
"jurisdiction_country": "BE"
}
],
"exchange_ratio": null,
"legal_articles": [
"556"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": null,
"real_estate_included": false,
"patrimony_description": "Geen overdracht van vermogen of reorganisatie; besluiten genomen overeenkomstig artikel 556 WVV in het kader van een bijzondere algemene vergadering van aandeelhouders.",
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0832.350.565",
"name_full": "Pharmafluidics",
"legal_form": "Naamloze Vennootschap"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "J\u0026P BVBA",
"person_name": null,
"org_rep_person_name": "JACOBS Paul"
},
"summary_narrative": "Op 6 juli 2016 hield de bijzondere algemene vergadering van aandeelhouders van Pharmafluidics, naamloze vennootschap met zetel te Zwijnaarde, een vergadering overeenkomstig artikel 556 van het Wetboek van Vennootschappen. De notulen van deze vergadering werden neergelegd bij de rechtbank van koophandel van Gent, afdeling Gent, op 18 augustus 2016.",
"co_filed_documents": [],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": "statutes"
}Genereer een gestructureerde, feitelijke nota op basis van alle signalen in dit dossier: risico, financiële gezondheid, eigendomsstructuur, mandaten en sectorvergelijking.
| Officiële naamNL | PharmaFluidics |